MedPath

Prospective Study of Clinical Utility of Acupuncture in Back Pain

Conditions
Back Pain
Musculoskeletal Disease
Registration Number
NCT01231425
Lead Sponsor
Group G-6
Brief Summary

The purpose of this study is to evaluate prospectively the effectiveness of acupuncture as adjunctive therapy in the treatment of spinal pain is the three backbone areas: cervical, thoracic and lumbar pain, under conditions of usual clinical practice as the medical acupuncturist performed acupuncture, with and without supplementary pharmacological treatment during the first 4 weeks of follow up.

Detailed Description

Epidemiological, observational, prospective, with two cohorts, naturalistic and non-interventionist study.

The disease to be studied is Back pain (cervical, thoracic or lumbar) caused by musculoskeletal pathologies and previously treated with conventional medical treatment with or without treatment currently.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
102
Inclusion Criteria
  • Patients of both sexes, aged 18 and over
  • Patients diagnosed with back pain: cervical, thoracic or lumbar.
  • Patients who has received appropriate medical treatment for their disease: analgesics, anti-inflammatories, or other treatments, but painful and symptoms persist
  • Patients that could receive acupuncture treatment in order to reduce the symptoms and reviewed by a medical acupuncturist
  • Patients with sufficient cultural and educational level to complete the health questionnaires required in the study
  • Patients who have given their written informed consent to participate in the study
Exclusion Criteria
  • Patient with any illness and that medical opinions recommended not to participate in the study
  • Patient can not respond to questionnaires administered during the study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
VAS: Visual Analogic Scale of pain10 weekly visits

Pain assesment will be evaluated using a Visual Analogic Scale of pain (VAS). This variable will be evaluated in all 10 visits and it will be showed its evolution (decrease) along the study

Secondary Outcome Measures
NameTimeMethod
Sheehan Disability QuestionnaireFirst Visit (week 1) and Final Visit (week 10)

Sheehan Disability Questionnaire, this validated questionnaire will be administrated in Visit 1 (Basal) and Visit 10 (Final) and it will be compared if there has been statistical differences between both evaluations

Evaluation of the Scale Hospital Anxiety Depression (HAD)First Visit (week 1) and Final Visit (week 10)

Scale Hospital Anxiety Depression (HAD), this scale will be evaluated using a validated questionnaire administrated in Visit 1 (basal) and Visit 10 (Final) and it will be compared if there has been statistical differences between both evaluations

Health Questionnaire EuroQol-5DFirst Visit (week 1) and Final Visit (week 10)

Health Questionnaire EuroQol-5D, this validated questionnaire will be administrated in Visit 1 (Basal) and Visit 10 (Final) and it will be compared if there has been statistical differences between both evaluations

Assessment of sleep with the integrated scale MOS (Medical Outcomes Study)First Visit (week 1) and Final Visit (week 10)

Assessment of sleep with the integrated scale MOS (Medical Outcomes Study), this scale will be evaluated using a validated questionnaire administrated in Visit 1 (basal) and Visit 10 (Final) and it will be compared if there has been statistical differences between both evaluations

McGill Pain Questionnaire10 weekly visits

A secondary evaluation of pain suffered by the patients will be evaluated using the validated McGill Pain Questionnaire. This questionnaire will be adminstrated in all 10 visits and it will be showed its evolution (decrease) along the study

Trial Locations

Locations (1)

I.H. Hospital San Jose

🇪🇸

Madrid, Spain

© Copyright 2025. All Rights Reserved by MedPath